Vitoss™ Bone Graft Substitute is the market leading synthetic bone graft with over 300,000 implantations worldwide. The success of Vitoss Bone Graft Substitute is founded on proven results and experience. Numerious human clinical studies (including prospective and peer reviewed) have demonstrated equivalence to iliac creast autograft, the gold standard. Vitoss Bioactive Bone Graft Substitute combines the optimized design of standard Vitoss with a unique bioactive additive that facilitates faster bone remodeling.
Vitoss and Vitoss Bioactive Bone Graft Substitute are intended to be used for filling bony voids or gaps of the skeletal system (i.e. the extremities, pelvis, and spine, which includes posterolateral fusion procedures), and may be combined with saline, autogenous blood, and/or bone marrow.